0001567619-19-015049.txt : 20190719
0001567619-19-015049.hdr.sgml : 20190719
20190719213635
ACCESSION NUMBER: 0001567619-19-015049
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190717
FILED AS OF DATE: 20190719
DATE AS OF CHANGE: 20190719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boucher Brent J.
CENTRAL INDEX KEY: 0001766229
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50761
FILM NUMBER: 19964401
MAIL ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANGIODYNAMICS INC
CENTRAL INDEX KEY: 0001275187
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 113146460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
BUSINESS PHONE: 5187981215
MAIL ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
4
1
doc1.xml
FORM 4
X0306
4
2019-07-17
0
0001275187
ANGIODYNAMICS INC
ANGO
0001766229
Boucher Brent J.
14 PLAZA DRIVE
LATHAM
NY
12110
0
1
0
0
SVP and GM of Oncology
Common Stock
2019-07-17
4
A
0
3226
0
A
16769
D
Non-Qualified Stock Option (right to buy)
21.54
2019-07-17
4
A
0
10790
0
A
2020-07-17
2029-07-17
Common Stock
10790
10790
D
This acquisition of 3,226 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 3,226 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal installments beginning on July 17, 2020, such that 25% of the restricted stock units will vest on each of July 17, 2020, 2021, 2022 and 2023.
These stock options vest in four equal annual installments beginning on July 17, 2020, such that 25% of the options will vest on each of July 17, 2020, 2021, 2022 and 2023.
/s/ Stephen A. Trowbridge, Attorney in Fact
2019-07-19